Explore GLP-1 treatment options What Is Semaglutide
[1] There is a theoretical concern regarding serotonin syndrome, though there is no established direct pharmacological mechanism for this interaction
Symptoms can include: Allergic reaction.* Potential for misuse and dependence.* Slowed growth in children. * For more information about this side effect, see Side effect details below
Both trials suggest maintenance strategies, such as lower-dose injections or oral therapies, could offer patients more flexible, potentially more convenient options for sustaining weight loss after intensive treatment
Include your BMI history, comorbidities, and relevant clinical trial data
More than a century later, the company became a leader in incretin biology, building the GLP-1/GIP dual agonist tirzepatide (Mounjaro/Zepbound) and following it with retatrutide and orforglipron, its oral non-peptide GLP-1 program